OrbiMed Genesis GP LLC's Net Worth

Estimate Recalculated Jun 11, 2025 11:46AM EST

Who is OrbiMed Genesis GP LLC

OrbiMed Genesis GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., Keros Therapeutics, Inc., PMV Pharmaceuticals, Inc., Theseus Pharmaceuticals, Inc., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., Kinnate Biopharma Inc., Ikena Oncology, Inc., Sierra Oncology, Inc., Galecto, Inc., Decibel Therapeutics, Inc., Compass Therapeutics, Inc., Terns Pharmaceuticals, Inc., Enliven Therapeutics, Inc., Disc Medicine, Inc., scPharmaceuticals Inc., Pandion Therapeutics Holdco LLC, ALPINE IMMUNE SCIENCES, INC., and LogicBio Therapeutics, Inc..

SEC CIK

OrbiMed Genesis GP LLC's CIK is 0001808744

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc.

Investor

Updated Jan 26, 2024


Form 4	47.01%	3.13M	$2.40	$7.50M	Jan 26, 2024	11.45M	Purchase	—	Jan 25
Form 4	12.10%	875.00K	$2.09	$1.83M	Jun 29, 2023	8.32M	Purchase	—	Jun 27
Form 4	765.30%	214.28K	$14.00	$3.00M	Dec 14, 2021	7.48M	Grant	—	Dec 10


Form 4	-19.70%	-250.00K	$44.01	-$11.00M	Aug 15, 2024	1.02M	Sale	—	Aug 13
Form 4	22.90%	375.20K	$16.00	$6.00M	Apr 13, 2020	2.01M	Purchase	—	Apr 13
Form 3	—	—	—	—	Apr 07, 2020	—	—	—	—


Form 4	-100.00%	-87.79K	$2.23	-$195.76K	Nov 24, 2023	6.48M	Sale	—	Nov 22
Form 4	-23.02%	-26.25K	$15.93	-$418.21K	May 31, 2022	6.56M	Sale	—	May 26
Form 4	-100.00%	-474.50K	$21.63	-$10.26M	Mar 31, 2022	6.59M	Sale	—	Mar 29 - Mar 31
Form 4	15.54%	950.00K	$18.00	$8.55M	Sep 29, 2020	7.06M	Purchase	—	Sep 25 - Sep 29
Form 3	—	—	—	—	Sep 24, 2020	—	—	—	—


Form 4	-100.00%	-17.71M	—	—	Feb 14, 2024	—	Disposition	—	Feb 14
Form 4	2.78%	479.93K	$3.05	$1.46M	Jul 19, 2023	17.71M	Purchase	—	Jul 17
Form 4	1.16%	192.00K	$5.21	$1.00M	Nov 09, 2022	17.23M	Purchase	—	Nov 07
Form 4	0.97%	158.42K	$9.97	$1.58M	Jan 21, 2022	17.04M	Purchase	—	Jan 19 - Jan 21
Form 4	0.27%	44.72K	$9.90	$442.75K	Jan 13, 2022	16.88M	Purchase	—	Jan 11 - Jan 13
Form 4	3.85%	625.00K	$16.00	—	Oct 14, 2021	16.84M	Purchase	—	Oct 12
Form 3	—	—	—	—	Oct 06, 2021	—	—	—	—


Form 4	-1.60%	-40.40K	$20.30	-$820.12K	Dec 30, 2021	2.49M	Sale	—	Dec 29
Form 4	-4.51%	-119.40K	$19.00	-$2.27M	Dec 23, 2021	2.53M	Sale	—	Dec 21
Form 4	-12.93%	-393.30K	$19.07	-$7.50M	Dec 17, 2021	2.65M	Sale	—	Dec 16
Form 4	66.79%	1.22M	$17.00	—	Jun 16, 2021	3.04M	Purchase	—	Jun 15
Form 3	—	—	—	—	Jun 10, 2021	—	—	—	—


Form 4	3.25%	454.55K	$11.00	$5.00M	Jan 25, 2024	14.76M	Purchase	—	Jan 23
Form 4	3.59%	484.50K	$10.32	$5.00M	Sep 16, 2022	14.30M	Purchase	—	Sep 16
Form 4	1.03%	138.00K	$7.21	$994.98K	May 20, 2022	13.82M	Purchase	—	May 18
Form 4	1.36%	359.38K	$16.00	$5.75M	Mar 31, 2021	26.73M	Purchase	—	Mar 30
Form 3	—	—	—	—	Mar 25, 2021	316.92K	—	—	—


Form 4	-100.00%	-8.01M	—	—	Apr 05, 2024	—	Disposition	—	Apr 03
Form 4	21.20%	1.46M	$2.78	$4.09M	May 08, 2023	8.89M	Purchase	—	May 04 - May 05
Form 4	10.11%	1.41M	$2.61	$3.67M	May 02, 2023	15.84M	Purchase	—	Apr 28 - May 02
Form 4	—	1.10M	—	—	Feb 23, 2023	5.14M	Grant	—	Feb 17
Form 4	5.91%	195.70K	$10.17	$1.99M	Feb 15, 2022	4.04M	Purchase	—	Feb 11 - Feb 15
Form 4	0.01%	478.00	—	—	Dec 09, 2020	3.85M	Options	—	Dec 07
Form 3	—	—	—	—	Dec 02, 2020	—	—	—	—


Form 4/A	9.33%	506.31K	—	—	Sep 21, 2023	8.28M	Grant	—	Aug 04
Form 4	24.13%	506.31K	—	—	Sep 14, 2023	8.28M	Grant	—	Aug 04
Form 4	-12.74%	-252.22K	$4.47	-$1.13M	Jun 24, 2022	7.78M	p	—	Jun 22 - Jun 24
Form 4/A	125.29%	10.79M	$8.70	$21.27M	Apr 13, 2021	19.40M	Purchase	—	Dec 21 - Mar 30
Form 4	120.10%	10.79M	$8.70	$21.27M	Apr 01, 2021	19.78M	Purchase	—	Dec 21 - Mar 30
Form 3	—	—	—	—	Mar 25, 2021	—	—	—	—


Form 4	-100.00%	-3.44M	$55.00	-$108.06M	Jul 01, 2022	—	Disposition	—	Jul 01
Form 4	—	—	$13.20	$6.43M	Jan 28, 2022	1.96M	Options	—	Jan 26


Form 4	-26.87%	-822.68K	$0.75	-$617.01K	Aug 17, 2023	2.24M	Sale	—	Aug 15
Form 4	-6.29%	-209.40K	$3.00	-$628.20K	Aug 02, 2023	3.12M	Sale	—	Jul 31
Form 4	-1.16%	-39.20K	$2.92	-$114.46K	Jul 27, 2023	3.33M	Sale	—	Jul 25
Form 4	-5.46%	-194.70K	$2.40	-$467.28K	Jul 17, 2023	3.37M	Sale	—	Jul 13
Form 4	-0.63%	-68.48K	$1.88	-$128.26K	Apr 17, 2023	10.76M	Sale	—	Apr 13 - Apr 17
Form 4	-0.61%	-67.54K	$1.81	-$121.36K	Apr 12, 2023	10.96M	Sale	—	Apr 10 - Apr 12
Form 4	-1.37%	-102.63K	$2.09	-$221.99K	Apr 07, 2023	7.41M	Sale	—	Apr 05 - Apr 06
Form 4	50.65%	2.34M	$21.06	$3.37M	Nov 04, 2020	6.96M	Purchase	—	Sep 25 - Nov 02
Form 3	—	—	—	—	Oct 28, 2020	—	—	—	—


Form 4	-60.83%	-12.43M	$18.00	$30.00M	Feb 19, 2021	8.01M	Buy-Options	—	Feb 17
Form 3	—	—	—	—	Feb 11, 2021	—	—	—	—


Form 4	2.71%	402.00K	$3.21	$1.29M	Nov 10, 2022	18.79M	Purchase	—	Nov 08
Form 4	1.32%	192.52K	$2.18	$420.48K	May 13, 2022	18.39M	Purchase	—	May 11 - May 13
Form 4	0.86%	125.36K	$1.57	$197.25K	May 10, 2022	18.20M	Purchase	—	May 06 - May 10
Form 4	42.13%	5.36M	$3.50	$18.75M	Nov 08, 2021	18.07M	Purchase	—	Nov 04


Form 4	-0.37%	-56.16K	$10.00	-$561.64K	Jul 17, 2024	15.13M	Sale	Scheduled	Jul 15 - Jul 16
Form 4	2.91%	137.93K	$7.25	$1.00M	Dec 28, 2022	7.62M	Purchase	—	Dec 23
Form 4	105.51%	4.00M	$2.42	$8.93M	Aug 18, 2022	7.79M	Purchase	—	Aug 16


Form 4	-11.54%	-1.03M	$22.14	-$22.88M	May 20, 2024	7.92M	Sale	—	May 16
Form 4	—	—	$4.28	$9.10K	May 19, 2023	8.95M	Options	—	May 17
Form 4	752.51%	7.90M	—	—	Feb 27, 2023	8.95M	Grant	—	Feb 23


Form 4	4.90%	83.33K	$36.00	$3.00M	Jun 20, 2024	1.79M	Purchase	—	Jun 17
Form 4	-100.00%	-1.72K	$48.62	-$36.62K	Dec 20, 2023	1.70M	Sale	—	Dec 18
Form 4	-20.29%	-433.20K	$56.75	-$24.58M	Dec 15, 2023	1.70M	Sale	—	Dec 14
Form 4	-2.11%	-134.20K	$58.95	-$7.90M	Dec 14, 2023	6.23M	Sale	—	Dec 12 - Dec 14
Form 4	5.03%	108.70K	$23.00	$2.50M	Feb 17, 2023	2.27M	Purchase	—	Feb 15
Form 4	—	2.16M	—	—	Jan 03, 2023	2.16M	Acq/Dis	—	Dec 29
Form 3	—	—	—	—	Jan 03, 2023	1.58M	—	—	—


Form 4	8.99%	500.00K	$4.00	$2.00M	Aug 15, 2024	6.06M	Purchase	—	Aug 13
Form 4	16.70%	762.38K	$5.25	$4.00M	Nov 29, 2022	5.56M	Purchase	—	Nov 25
Form 4	40.68%	1.39M	$8.65	$12.00M	May 26, 2020	4.80M	Purchase	—	May 21


Form 4	-100.00%	-2.68M	—	—	May 20, 2024	—	Disposition	—	May 18
Form 4	—	—	$12.74	$1.85M	Jan 16, 2024	2.68M	Options	—	Jan 11
Form 4	-13.05%	-1.55M	$19.37	-$28.67M	Dec 29, 2023	10.31M	Sale	—	Dec 27 - Dec 28
Form 4	32.91%	1.01M	$9.40	$9.50M	Sep 21, 2021	4.08M	Purchase	—	Sep 17


Form 4	-89.64%	-33.00M	$16.00	—	Sep 17, 2024	3.81M	Buy-Options	—	Sep 16
Form 3	—	—	—	—	Sep 12, 2024	—	—	—	—

OrbiMed Genesis GP LLC's Net Worth

Who is OrbiMed Genesis GP LLC

SEC CIK

Past Insider Trading and Trends

Adicet Bio, Inc.

Keros Therapeutics, Inc.

PMV Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

Janux Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Kinnate Biopharma Inc.

Ikena Oncology, Inc.

Sierra Oncology, Inc.

Galecto, Inc.

Decibel Therapeutics, Inc.

Compass Therapeutics, Inc.

Terns Pharmaceuticals, Inc.

Enliven Therapeutics, Inc.

Disc Medicine, Inc.

scPharmaceuticals Inc.

Pandion Therapeutics Holdco LLC

ALPINE IMMUNE SCIENCES, INC.

LogicBio Therapeutics, Inc.

MBX Biosciences, Inc.